Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir

被引：51

作者：

Bonfanti, Paolo ^{[1
]}

Madeddu, Giordano ^{[2
]}

Gulminetti, Roberto ^{[3
]}

Squillace, Nicola ^{[4
]}

Orofino, Giancarlo ^{[5
]}

Vitiello, Paola ^{[6
]}

Rusconi, Stefano ^{[7
]}

Celesia, Benedetto M. ^{[8
]}

Maggi, Paolo ^{[9
]}

Ricci, Elena ^{[10
]}

机构：

[1] A Manzoni Hosp, Infect Dis Unit, Via Eremo 9, I-23900 Lecce, Italy

[2] Univ Sassari, Dept Clin & Expt Med, Infect Dis Unit, Sassari, Italy

[3] San Matteo Hosp, Infect Dis Unit, Pavia, Italy

[4] Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Infect Dis Clin, Monza, Italy

[5] Amedeo Savoia Hosp, Dept Infect Dis, Turin, Italy

[6] ASST Valle Olona, Infect Dis Unit, Busto Arsizio, Italy

[7] Univ Milan, Infect Dis Unit, DIBIC Luigi Sacco, Milan, Italy

[8] Garibaldi Hosp, Infect Dis Unit, Catania, Italy

[9] Univ Bari, Infect Dis Unit, Bari, Italy

[10] ASST Fatebenefratelli Sacco, Dept Infect Dis, Milan, Italy

来源：

AIDS | 2017年 / 31卷 / 03期

关键词：

D O I：

10.1097/QAD.0000000000001351

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：455 / 457

页数：3

共 5 条

[1] An Italian approach to postmarketing monitoring: Preliminary results from the SCOLTA (Surveillance cohort long-term toxicity antiretrovirals) Project on the safety of lopinavir/ritonavir [J].

Bonfanti, P ;

Martinelli, C ;

Ricci, E ;

Carradori, S ;

Parruti, G ;

Armignacco, O ;

Magnani, C ;

Quirino, T .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (03) :317-320

[2] Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study [J].

Cahn, Pedro ;

Pozniak, Anton L. ;

Mingrone, Horacio ;

Shuldyakov, Andrey ;

Brites, Carlos ;

Andrade-Villanueva, Jaime F. ;

Richmond, Gary ;

Beltran Buendia, Carlos ;

Fourie, Jan ;

Ramgopal, Moti ;

Hagins, Debbie ;

Felizarta, Franco ;

Madruga, Jose ;

Reuter, Tania ;

Newman, Tamara ;

Small, Catherine B. ;

Lombaard, John ;

Grinsztejn, Beatriz ;

Dorey, David ;

Underwood, Mark ;

Griffith, Sandy ;

Min, Sherene .

LANCET, 2013, 382 (9893) :700-708

[3] Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice [J].

de Boer, Mark G. J. ;

van den Berk, Guido E. L. ;

van Holten, Natasja ;

Oryszcyn, Josephine E. ;

Dorama, Willemien ;

Moha, Daoud Ait ;

Brinkman, Kees .

AIDS, 2016, 30 (18) :2831-2834

[4] Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials [J].

Raffi, Francois ;

Rachlis, Anita ;

Brinson, Cynthia ;

Arasteh, Keikawus ;

Gorgolas, Miguel ;

Brennan, Clare ;

Pappa, Keith ;

Almond, Steve ;

Granier, Catherine ;

Nichols, W. Garrett ;

Cuffe, Robert Liam ;

Eron, Joseph, Jr. ;

Walmsley, Sharon .

AIDS, 2015, 29 (02) :167-174

[5] Dolutegravir plus Abacavir-Lamivudine for the Treatment of HIV-1 Infection [J].

Walmsley, Sharon L. ;

Antela, Antonio ;

Clumeck, Nathan ;

Duiculescu, Dan ;

Eberhard, Andrea ;

Gutierrez, Felix ;

Hocqueloux, Laurent ;

Maggiolo, Franco ;

Sandkovsky, Uriel ;

Granier, Catherine ;

Pappa, Keith ;

Wynne, Brian ;

Min, Sherene ;

Nichols, Garrett .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (19) :1807-1818

← 1 →